| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9114687 | Growth Hormone & IGF Research | 2005 | 7 Pages |
Abstract
Intravenous octreotide reduces GH to concentrations <5Â mU/L in â¼50% of consecutive patients with active acromegaly, which predicts a good response to chronic octreotide-LAR treatment.
Keywords
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Endocrinology
Authors
Nienke R. Biermasz, Alberto M. Pereira, Jan W.A. Smit, Johannes A. Romijn, Ferdinand Roelfsema,